Efficacy, patient reported outcomes and safety of gusacitinib in chronic hand eczema: Results of a phase 2b, randomized, double-blind, placebo-controlled study
In this medfyle
Expert commentary by Zelma C. Chiesa Fuxench, MD MSCE
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the AAD Virtual Meeting Experience 2021 and presented by:
Howard Sofen, MD
Dermatology Division Chief, UCLA Olive View Medical Center
Los Angeles, CA, USA
The content is produced by Infomedica, the official reporting partner of AAD VMX 2021. The summary text was drafted by Marie Farrow for Medfyle, and reviewed by Martina Lambertini, MD, an independent external expert, and approved by Hassan Galadari, MD, FAAD, the scientific editor of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Zelma C. Chiesa Fuxench, MD MSCE
University of Pennsylvania Perelman School of Medicine
About the Expert
Zelma C. Chiesa Fuxench, MD MSCE
University of Pennsylvania Perelman School of Medicine
Dr. Chiesa Fuxench is an Assistant Professor of Dermatology at the University of Pennsylvania (Penn), USA. She completed her medical school and dermatology residency training at the University of Puerto Rico School of Medicine and then went on to pursue a Master of Science in Clinical Epidemiology at Penn. Dr. Chiesa’s clinical practice is focused on the care of patients with inflammatory skin diseases including atopic dermatitis. Her research work is focused on improving our understanding of the epidemiology, natural course, and comorbidities of these diseases through investigator-driven collaborative work and by engaging in clinical trials for novel therapeutic interventions. Her research has been supported by Women’s Dermatological Society, Dermatology Foundation, National Psoriasis Foundation and has been published in various peer-reviewed journals. As a member of various professional organizations, including the American Academy of Dermatology, Dr. Chiesa participates in several committees and initiatives such as AAD’s Council for Science and Research.
References
1. Dubin C, Del Duca E, Guttman-Yassky E. Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges. Ther Clin Risk Manag 2020;16:1319–32.
